Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts → Write this ticker symbol down… (From StocksToTrade) (Ad) Free RNA Stock Alerts $39.64 -0.32 (-0.80%) (As of 06/14/2024 08:51 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 15) -$0.79 Beat By $0.02 Consensus EPS (May. 15) -$0.81 Get Avidity Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for RNA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RNA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. Avidity Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.78)($0.78)($0.78)Q2 20241($0.80)($0.80)($0.80)Q3 20241($0.83)($0.83)($0.83)Q4 20241($0.86)($0.86)($0.86)FY 20244($3.27)($3.27)($3.27)RNA Earnings Date and InformationAvidity Biosciences last released its earnings data on May 15th, 2024. The biotechnology company reported ($0.79) earnings per share for the quarter, beating analysts' consensus estimates of ($0.81) by $0.02. The company earned $3.54 million during the quarter, compared to analyst estimates of $7.09 million. Avidity Biosciences has generated ($2.95) earnings per share over the last year (($2.95) diluted earnings per share). Earnings for Avidity Biosciences are expected to decrease in the coming year, from ($3.10) to ($3.28) per share. Avidity Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Avidity Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/15/2024-($0.81)($0.79)+$0.02($0.79)$7.09 million$3.54 million2/28/2024Q4 2023($0.54)($0.79)($0.25)($0.79)$32.08 million$2.19 million11/8/2023Q3 2023($0.76)($0.71)+$0.05($0.71)$2.09 million$2.82 million8/8/2023Q2 2023($0.84)($0.66)+$0.18($0.66)$2.09 million$2.32 million5/9/2023Q1 2023($0.90)($0.74)+$0.16($0.74)$2.08 million$2.23 million2/28/2023Q4 2022($0.84)($0.88)($0.04)($0.88)$2.39 million$2.77 million Get the Latest News and Ratings for RNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.97)($0.82)+$0.15($0.82)$2.39 million$2.48 million8/9/2022Q2 2022($0.74)($0.92)($0.18)($0.92)$2.29 million$2.18 million5/10/2022Q1 2022($0.94)($0.71)+$0.23($0.71)$1.50 million$1.80 million3/1/2022Q4 2021($0.73)($0.82)($0.09)($0.82)$2.20 million$1.85 million11/9/2021Q3 2021($0.68)($0.68)-($0.68)$1.50 million$2.16 million8/8/2021Q2 2021($0.71)($0.70)+$0.01($0.70)$1.50 million$2.61 million5/11/2021Q1 2021($0.56)($0.64)($0.08)($0.64)$1.50 million$2.70 million3/14/2021Q4($0.3430)($0.43)($0.0870)($0.43)-$2.14 million11/10/2020Q3 2020($0.37)($0.31)+$0.06($0.31)-$1.75 million8/10/2020Q2($0.24)($1.23)($0.99)($1.23)-$1.54 million Avidity Biosciences Earnings - Frequently Asked Questions When is Avidity Biosciences's earnings date? Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on RNA's earnings history. Did Avidity Biosciences beat their earnings estimates last quarter? In the previous quarter, Avidity Biosciences (NASDAQ:RNA) reported ($0.79) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.81) by $0.02. Learn more on analysts' earnings estimate vs. RNA's actual earnings. How much revenue does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $9.56 million. How much profit does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$212.22 million. RNA has generated -$2.95 earnings per share over the last four quarters. What is Avidity Biosciences's EPS forecast for next year? Avidity Biosciences's earnings are expected to decrease from ($3.10) per share to ($3.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ORIC Pharmaceuticals Earnings Results Nkarta Earnings Results Solid Biosciences Earnings Results Elanco Animal Health Earnings Results Insmed Earnings Results Roivant Sciences Earnings Results Legend Biotech Earnings Results Ascendis Pharma A/S Earnings Results Cerevel Therapeutics Earnings Results Intra-Cellular Therapies Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:RNA) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.